---
title: "Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279192193.md"
description: "Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions"
datetime: "2026-03-16T02:32:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279192193.md)
  - [en](https://longbridge.com/en/news/279192193.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279192193.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/279192193.md) | [繁體中文](https://longbridge.com/zh-HK/news/279192193.md)


# Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions

Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions

### Related Stocks

- [Mustang Bio, Inc. (MBIO.US)](https://longbridge.com/en/quote/MBIO.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [Direxion Daily S&P Biotech Bull 3X ETF (LABU.US)](https://longbridge.com/en/quote/LABU.US.md)
- [Cambium Networks Corporation (CMBM.US)](https://longbridge.com/en/quote/CMBM.US.md)
- [CAMBIUM NETWORKS CORPORATION (CMBMF.US)](https://longbridge.com/en/quote/CMBMF.US.md)

## Related News & Research

- [Anthropic acquires startup Coefficient Bio for about $400 million - The Information](https://longbridge.com/en/news/281587005.md)
- [09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104](https://longbridge.com/en/news/281025352.md)
- [Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat](https://longbridge.com/en/news/281233412.md)
- [BUZZ-Caribou rises on FDA's regenerative medicine advanced therapy tag for blood cancer therapy](https://longbridge.com/en/news/281186075.md)
- [Teva receives FDA approval for Prolia biosimilar](https://longbridge.com/en/news/281172040.md)